M Michelle Berrey - Net Worth and Insider Trading
M Michelle Berrey Net Worth
The estimated net worth of M Michelle Berrey is at least $586,419 dollars as of 2023-06-09. M Michelle Berrey is the President and CEO of Chimerix Inc and owns about 424,941 shares of Chimerix Inc (CMRX) stock worth over $586,419. Details can be seen in M Michelle Berrey's Latest Holdings Summary section.
Transaction Summary of M Michelle Berrey
M Michelle Berrey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, M Michelle Berrey owns 3 companies in total, including Chimerix Inc (CMRX) , Intercept Pharmaceuticals Inc (ICPT) , and Ocean Biomedical Inc (OCEA) .
Click here to see the complete history of M Michelle Berrey’s form 4 insider trades.
Insider Ownership Summary of M Michelle Berrey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2013-04-10 | Chief Medical Officer |
| ICPT | Intercept Pharmaceuticals Inc | 2021-06-14 | President & R&D and CMO |
| OCEA | Ocean Biomedical Inc | 2023-02-14 | director |
M Michelle Berrey Latest Holdings Summary
M Michelle Berrey currently owns a total of 1 stock. M Michelle Berrey owns 424,941 shares of Chimerix Inc (CMRX) as of June 12, 2018, with a value of $586,419.
Latest Holdings of M Michelle Berrey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMRX | Chimerix Inc | 2018-06-12 | 424,941 | 1.38 | 586,419 |
Holding Weightings of M Michelle Berrey
M Michelle Berrey Form 4 Trading Tracker
According to the SEC Form 4 filings, M Michelle Berrey has made a total of 1 transactions in Chimerix Inc (CMRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Chimerix Inc is the acquisition of 10,000 shares on June 12, 2018, which cost M Michelle Berrey around $45,000.
Insider Trading History of M Michelle Berrey
- 1
M Michelle Berrey Trading Performance
GuruFocus tracks the stock performance after each of M Michelle Berrey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by M Michelle Berrey is 15.78%. GuruFocus also compares M Michelle Berrey's trading performance to market benchmark return within the same time period. The performance of stocks bought by M Michelle Berrey within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how M Michelle Berrey's insider trading performs compared to the benchmark.
Performance of M Michelle Berrey
Average Relative Return
40.66%
Outperforming Transactions
80%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 15.31 | 15.78 | 27.73 | 40.66 | 0.81 | -14.85 |
| Relative Return to S&P 500(%) | 13.17 | 10.95 | 20.74 | 27.5 | -9.2 | -26.07 |
M Michelle Berrey Ownership Network
Ownership Network List of M Michelle Berrey
Ownership Network Relation of M Michelle Berrey
M Michelle Berrey Owned Company Details
What does Chimerix Inc do?
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.
Who are the key executives at Chimerix Inc?
M Michelle Berrey is the Chief Medical Officer of Chimerix Inc. Other key executives at Chimerix Inc include Chief Medical Officer Allen S. Melemed , 10 percent owner Cantex Pharmaceuticals, Inc. , and Principal Accounting Officer David Jakeman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, M Michelle Berrey made no insider transaction in Chimerix Inc (CMRX). Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 60,000 shares made by Fred A Middleton , a net sale of 10,930 shares made by David Jakeman , and a net purchase of 28,000 shares made by Martha J Demski .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 133,750 shares, with a net purchase of 133,750 shares. During the past 18 months, 10,930 shares of Chimerix Inc (CMRX) were sold and 198,750 shares were bought by its insiders, resulting in a net purchase of 187,820 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
M Michelle Berrey Mailing Address
Above is the net worth, insider trading, and ownership report for M Michelle Berrey. You might contact M Michelle Berrey via mailing address: 303a College Road East, Princeton Nj 08450.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
